Feasibility and safety of ultrasound-guided percutaneous microwave ablation for tertiary hyperparathyroidism

References

• Block GA, Martin KJ, de Francisco ALM, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004;350(15):1516–1525.
   PubMed Web of Science ®Google Scholar
• Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol. 2011;6(4):913.
   PubMed Web of Science ®Google Scholar
• Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2015;10(1):98.
   PubMed Web of Science ®Google Scholar
• Jamal SA, Miller PD. Secondary and tertiary hyperparathyroidism. J Clin Densitom. 2013;16(1):64–68.
   PubMed Web of Science ®Google Scholar
• Lou I, Schneider DF, Leverson G, et al. Parathyroidectomy is underused in patients with tertiary hyperparathyroidism after renal transplantation. Surgery. 2016;159(1):172–180.
   PubMed Web of Science ®Google Scholar
• Pitt SC, Sippel RS, Chen H. Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am. 2009;89(5):1227–1239.
   PubMed Web of Science ®Google Scholar
• Yang RL, Freeman K, Reinke CE, et al. Tertiary hyperparathyroidism in kidney transplant recipients: characteristics of patients selected for different treatment strategies. Transplantation. 2012;94(1):70–76.
   PubMed Web of Science ®Google Scholar
• Lee B, Qiao L, Lu M, et al. C/EBPα regulates macrophage activation and systemic metabolism. Am J Physiol Endocrinol Metab. 2014;306(10):E1144–E1154.
   PubMed Web of Science ®Google Scholar
• Eidman KE, Wetmore JB. Treatment of secondary hyperparathyroidism: how do cinacalcet and etelcalcetide differ? Semin Dial. 2018;31(5):440–444.
   PubMed Web of Science ®Google Scholar
• Triponez F, Clark OH, Vanrenthergem Y, et al. Surgical treatment of persistent hyperparathyroidism after renal transplantation. Ann Surg. 2008;248(1):18–30.
   PubMed Web of Science ®Google Scholar
• Kebebew E, Duh QY, Clark OH. Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy. Arch Surg. 2004;139(9):974–977.
   PubMedGoogle Scholar
• Tang JA, Salapatas AM, Bonzelaar LB, et al. Parathyroidectomy for the treatment of hyperparathyroidism: thirty-day morbidity and mortality. Laryngoscope. 2018;128(2):528–533.
   PubMed Web of Science ®Google Scholar
• Drakopoulos S, Koukoulaki M, Apostolou T, et al. Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation. Am J Surg. 2009;198(2):178–183.
   PubMed Web of Science ®Google Scholar
• Evenepoel P, Claes K, Kuypers D, et al. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transplant. 2005;20(8):1714–1720.
   PubMed Web of Science ®Google Scholar
• Gasparri G, Camandona M, Abbona GC, et al. Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg. 2001;233(1):65–69.
   PubMed Web of Science ®Google Scholar
• Chen HH, Lin CJ, Wu CJ, et al. Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy. Ann Surg. 2011;253(4):786–790.
   PubMed Web of Science ®Google Scholar
• Douthat WG, Cardozo G, Garay G, et al. Use of percutaneous ethanol injection therapy for recurrent secondary hyperparathyroidism after subtotal parathyroidectomy. Int J Nephrol. 2011;2011:1.
   Google Scholar
• Onoda N, Kurihara S, Sakurai Y, et al. A case of secondary hyperparathyroidism whose high turnover bone improved after the direct injection of acetic acid into the parathyroid glands. Clin Nephrol. 2004;61(1):68–73.
   PubMed Web of Science ®Google Scholar
• Bennedbaek FN, Karstrup S, Hegedüs L. Ultrasound guided laser ablation of a parathyroid adenoma. Br J Radiol. 2001;74(886):905–907.
   PubMed Web of Science ®Google Scholar
• Kovatcheva RD, Vlahov JD, Stoinov JI, et al. High-intensity focussed ultrasound (HIFU) treatment in uraemic secondary hyperparathyroidism. Nephrol Dial Transplant. 2012;27(1):76–80.
   PubMed Web of Science ®Google Scholar
• Carrafiello G, Laganà D, Mangini M, et al. Treatment of secondary hyperparathyroidism with ultrasonographically guided percutaneous radiofrequency thermoablation. Surg Laparosc Endosc Percutan Tech. 2006;16(2):112–116.
   PubMed Web of Science ®Google Scholar
• Yue W, Wang S, Wang B, et al. Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: safety and imaging follow-up in 222 patients. Eur J Radiol. 2013;82(1):e11–e16.
   PubMed Web of Science ®Google Scholar
• Zhao J, Qian L, Zu Y, et al. Efficacy of ablation therapy for secondary hyperparathyroidism by ultrasound guided percutaneous thermoablation. Ultrasound Med Biol. 2016;42(5):1058–1065.
   PubMed Web of Science ®Google Scholar
• Zhuo L, Peng L-L, Zhang Y-M, et al. US-guided microwave ablation of hyperplastic parathyroid glands: safety and efficacy in patients with end-stage renal disease – a pilot study. Radiology. 2017;282(2):576–584.
   PubMed Web of Science ®Google Scholar
• Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18(6):1244–1250.
   PubMed Web of Science ®Google Scholar
• Wong KP, Lang BHH. Use of radiofrequency ablation in benign thyroid nodules: a literature review and updates. Int J Endocrinol. 2013;2013:428363.
   PubMed Web of Science ®Google Scholar
• Na DG, Lee JH, Jung SL, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol. 2012;13(2):117–125.
   PubMed Web of Science ®Google Scholar
• Baek JH, Kim YS, Lee D, et al. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. Am J Roentgenol. 2010;194(4):1137–1142.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59.
   PubMed Web of Science ®Google Scholar
• Mauri G, Cova L, Ierace T, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol. 2016;39(7):1023–1030.
   PubMed Web of Science ®Google Scholar
• Wang R, Jiang T, Chen Z, et al. Regression of calcinosis following treatment with radiofrequency thermoablation for severe secondary hyperparathyroidism in a hemodialysis patient. Intern Med. 2013;52(5):583–587.
   PubMed Web of Science ®Google Scholar
• Hinshaw JL, Lubner MG, Ziemlewicz TJ, et al. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation – what should you use and why? Radiographics. 2014;34(5):1344–1362.
   PubMed Web of Science ®Google Scholar
• Andreano A, Huang Y, Meloni MF, et al. Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue. Med Phys. 2010;37(6):2967–2973.
   PubMed Web of Science ®Google Scholar
• Diao Z, Wang L, Li D, et al. Efficacy of microwave ablation for severe secondary hyperparathyroidism in subjects undergoing hemodialysis. Ren Fail. 2017;39(1):140–145.
   PubMed Web of Science ®Google Scholar
• Kovatcheva R, Vlahov J, Stoinov J, et al. US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism. Eur Radiol. 2014;24(9):2052–2058.
   PubMed Web of Science ®Google Scholar
• Li X, An C, Yu M, et al. US-guided microwave ablation for secondary hyperparathyroidism in patients after renal transplantation: a pilot study. Int J Hyperthermia. 2019;36(1):322–327.
   PubMed Web of Science ®Google Scholar